Cargando…

Circular RNA: A novel type of biomarker for glioma

With the rapid development of sequencing technologies, the characteristics and functions of circular RNAs (circRNAs) in different tissues, and their underlying pathophysiological mechanisms, have been identified. circRNAs are significantly enriched in the brain and are continually expressed from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wei, Zhou, Huandi, Han, Xuetao, Hou, Liubing, Xue, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240176/ https://www.ncbi.nlm.nih.gov/pubmed/34165178 http://dx.doi.org/10.3892/mmr.2021.12240

Ejemplares similares

SDPS-17 COMPREHENSIVE ANALYSIS OF CELL DIVISION CYCLE ASSOCIATED GENE FAMILY EXPRESSION PATTERN AND PROGNOSIS VALUE REVEALS CDCA2 AS A NOVEL ONCOGENE FOR GLIOMA
por: Sun, Wei, et al.
Publicado: (2023)

SDPS-28 THE STUDY OF AN ANOIKIS-RELATED SIGNATURE TO PREDICT GLIOMA PROGNOSIS AND IMMUNE INFILTRATION
por: Zhang, Dongdong, et al.
Publicado: (2023)

SYST-23 CDK1 AS AN INDEPENDENT PROGNOSTIC INDICATOR AND POTENTIAL THERAPEUTIC TARGET IN GLIOMA
por: Wang, Yu, et al.
Publicado: (2023)

IDH1(R132H) mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas
por: Han, Xuetao, et al.
Publicado: (2023)

A molecular view of the radioresistance of gliomas
por: Han, Xuetao, et al.
Publicado: (2017)

SYST-16 ANXA5 PROMOTES GLIOMA PROGRESSION THROUGH THE FAK/PI3K/AKT PATHWAY
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Upregulated Expression of Cancer-Derived Immunoglobulin G Is Associated With Progression in Glioma
por: Wang, Guohui, et al.
Publicado: (2021)

Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma
por: Hou, Liubing, et al.
Publicado: (2022)

A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment
por: Li, Haonan, et al.
Publicado: (2021)

A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma
por: Wang, Guohui, et al.
Publicado: (2021)

DNMT family induces down-regulation of NDRG1 via DNA methylation and clinicopathological significance in gastric cancer
por: Chang, Xiaojing, et al.
Publicado: (2021)

NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2022)

The current management of alveolar soft part sarcomas
por: Chang, Xiaojing, et al.
Publicado: (2021)

ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma
por: Zhang, Dongdong, et al.
Publicado: (2022)

Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2021)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

Circular RNAs: A novel type of biomarker and genetic tools in cancer
por: Han, Yi-Neng, et al.
Publicado: (2017)

A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 Glioma
por: Gao, Qi, et al.
Publicado: (2022)

Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
por: Yang, Yibing, et al.
Publicado: (2017)

Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
por: Meng, Hongwu, et al.
Publicado: (2022)

The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
por: Tian, Lei, et al.
Publicado: (2021)

Circular RNA: a novel biomarker and therapeutic target for human cancers
por: Lei, Bo, et al.
Publicado: (2019)

Circular RNAs: Novel Promising Biomarkers in Ocular Diseases
por: Guo, Nan, et al.
Publicado: (2019)

Research Progress on Circular RNA in Glioma
por: Chen, Mengyu, et al.
Publicado: (2021)

Circular RNAs and human glioma
por: Liu, Jinglei, et al.
Publicado: (2019)

Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome
por: Jing, Tianrui, et al.
Publicado: (2023)

Circular RNA and its potential as prostate cancer biomarkers
por: Tucker, Dwayne, et al.
Publicado: (2020)

Functions and clinical significance of circular RNAs in glioma
por: Sun, Jikui, et al.
Publicado: (2020)

Circular RNA profile in gliomas revealed by identification tool UROBORUS
por: Song, Xiaofeng, et al.
Publicado: (2016)

Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer
por: Shi, Yuchuan, et al.
Publicado: (2020)

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Circular RNA expression profile of systemic lupus erythematosus and its clinical significance as a potential novel biomarker
por: Li, Wenyu, et al.
Publicado: (2022)

Circular RNA in gastric cancer
por: Li, Xue-Wei, et al.
Publicado: (2020)

Circular RNA as a Possible Novel Biomarker for Kawasaki Disease
por: Yoon, Kyung Lim
Publicado: (2019)

Circular RNAs as novel potential biomarkers for pancreatic cancer
por: Liu, Shanshan, et al.
Publicado: (2021)

Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity
por: Wang, Man, et al.
Publicado: (2017)

MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients
por: Wu, Haibin, et al.
Publicado: (2019)

An intriguing RNA species—perspectives of circularized RNA
por: Shen, Ting, et al.
Publicado: (2015)

The potential of using blood circular RNA as liquid biopsy biomarker for human diseases
por: Wen, Guoxia, et al.
Publicado: (2020)

Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545
por: Zhang, Xuebang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ccec3sdm453sfb6v7tuitco9us